Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|February 12, 2018

Tosoh Bioscience

Tosoh Bioscience offers a comprehensive line of products including TSKgel® and TOYOPEARL® bulk media, process development products, TSKgel U/HPLC columns, as well as a unique EcoSEC® GPC System for polymer characterization.

Tosoh Bioscience offers a comprehensive line of products including TSKgel® and TOYOPEARL® bulk media, process development products, TSKgel U/HPLC columns, as well as a unique EcoSEC® GPC System for polymer characterization. These products satisfy the needs of the biochemist and the biotechnologist involved in analyzing, isolating, and purifying proteins, peptides, enzymes, oligonucleotides, antibiotics, and small biomolecules. Visit us at Pittcon booth #2610.

Related to this article

The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
FDA clears the IND for Biolojic Design’s BD200, an AI-designed Trop2/Nectin-4 multibody ADC; Blackstone Life Sciences agrees to provide Pfizer up to $1.5 billion to develop its monthly GLP-1 receptor agonist berobenatide; and enGene Therapeutics plans a year-end BLA for detalimogene voraplasmid in BCG-unresponsive non-muscle invasive bladder cancer.